A detailed history of Bank Of America Corp transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 671,950 shares of SAGE stock, worth $3.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
671,950
Previous 510,881 31.53%
Holding current value
$3.68 Million
Previous $5.55 Million 12.69%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.02 - $13.08 $1.13 Million - $2.11 Million
161,069 Added 31.53%
671,950 $4.84 Million
Q2 2024

Aug 14, 2024

SELL
$10.58 - $17.9 $145,094 - $245,480
-13,714 Reduced 2.61%
510,881 $5.55 Million
Q1 2024

May 15, 2024

BUY
$18.62 - $26.95 $4.75 Million - $6.87 Million
255,044 Added 94.62%
524,595 $9.83 Million
Q4 2023

Feb 14, 2024

BUY
$17.1 - $22.26 $2.28 Million - $2.97 Million
133,607 Added 98.28%
269,551 $5.84 Million
Q2 2023

Aug 14, 2023

SELL
$40.65 - $59.54 $6.02 Million - $8.82 Million
-148,057 Reduced 52.13%
135,944 $6.39 Million
Q1 2023

May 12, 2023

BUY
$37.27 - $46.57 $1.37 Million - $1.71 Million
36,790 Added 14.88%
284,001 $11.9 Million
Q4 2022

Feb 10, 2023

BUY
$32.2 - $43.61 $1.67 Million - $2.27 Million
51,995 Added 26.63%
247,211 $9.43 Million
Q3 2022

Nov 14, 2022

BUY
$32.28 - $43.27 $1.27 Million - $1.7 Million
39,295 Added 25.2%
195,216 $7.65 Million
Q2 2022

Aug 12, 2022

SELL
$27.52 - $37.99 $2.34 Million - $3.24 Million
-85,167 Reduced 35.33%
155,921 $5.04 Million
Q1 2022

May 16, 2022

BUY
$30.71 - $45.71 $3.04 Million - $4.53 Million
98,996 Added 69.67%
241,088 $7.98 Million
Q4 2021

Feb 08, 2022

BUY
$37.06 - $47.11 $2.25 Million - $2.86 Million
60,790 Added 74.77%
142,092 $6.04 Million
Q3 2021

Nov 15, 2021

SELL
$40.26 - $57.37 $1.05 Million - $1.5 Million
-26,137 Reduced 24.33%
81,302 $3.6 Million
Q2 2021

Sep 13, 2021

BUY
$54.88 - $79.29 $5.9 Million - $8.52 Million
107,439 New
107,439 $6.1 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.